Grant: Catalyst Grant: Human Microbiome
University of Calgary
$87,500.00
Elusive respiratory pathogens in the oropharyngeal flora
EF 2008-09
Résumé
The organisms responsible for up to 30% of bacterial respiratory infections are not identified in the clinical laboratory and consequently are treated empirically by physicians. The bacteria responsible are often members of the normal microbiome, residents of the oral/nasal cavity that can be pathogenic when they grow in the lower respiratory tract. We have previously identified two groups of bacteria (Streptococcus Milleri and Gemella spp) that account for up to 50% of hospitalizations in adult cystic fibrosis. We will extend our studies into bacterial pneumonias and non-CF bronchiectasis using molecular and microbiological approaches. This preliminary study will focus on identifying common pathogens in these cases and in developing improved methods for detection and characterization of the organisms present. A significant effort will focus on the Streptococci which are a diverse and in terms of the normal flora, a poorly characterized group of bacteria.
Programme
Catalyst Grant: Human Microbiome
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
172996
Name
Surette Michael G
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Catalyst Grant: Human Microbiome
Projecttitle
Elusive respiratory pathogens in the oropharyngeal flora
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$87,500
Cihrequipment2
$7,500
Programname2
Catalyst Grant: Human Microbiome
Keyworddelim
Bacterial Pneumonia; Bronchiectasis; Gemella; Oropharyngeal Flora; Respiratory Infection; Streptococcus
Abstract
The organisms responsible for up to 30% of bacterial respiratory infections are not identified in the clinical laboratory and consequently are treated empirically by physicians. The bacteria responsible are often members of the normal microbiome, residents of the oral/nasal cavity that can be pathogenic when they grow in the lower respiratory tract. We have previously identified two groups of bacteria (Streptococcus Milleri and Gemella spp) that account for up to 50% of hospitalizations in adult cystic fibrosis. We will extend our studies into bacterial pneumonias and non-CF bronchiectasis using molecular and microbiological approaches. This preliminary study will focus on identifying common pathogens in these cases and in developing improved methods for detection and characterization of the organisms present. A significant effort will focus on the Streptococci which are a diverse and in terms of the normal flora, a poorly characterized group of bacteria.
Competitiondate
200808
Approvedterm2
1 yr 0 mth
Pinamesdelim
Surette, Michael G
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Circ &Respiratory Hlth~ $87,500~ $7,500~